Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 276–300 of 7,816 matching trials · page 12 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The Impact of Music Intervention on Sleep NCT06088810 CoMPoSER intervention group; Sleep Education Runs in: United States · 1 site |
NA other |
RECRUITING | 144 | Duke University OTHER |
2026-08-25 |
|
MCI Speech in Noise NCT06102486 Runs in: United States · 1 site |
NA other |
RECRUITING | 70 | Dartmouth-Hitchcock Medical Center OTHER |
2026-08-25 |
|
Recombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical Trial NCT06489015 Recombinant Human Serum Albumin Runs in: China · 5 sites |
EARLY_PHASE1 other |
COMPLETED | 30 | Shenzhen Protgen Co., Ltd. INDUSTRY |
2026-08-25 |
|
Efficacy of a Multidomain Intervention on Lifestyle Risk Factors for Dementia Prevention NCT06748625 Luci Coach-Assisted Intervention Runs in: Canada · 1 site |
PHASE3 other |
ACTIVE_NOT_RECRUITING | 370 | LuciLab INDUSTRY |
2026-08-25 |
|
AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults NCT07701668 AI-based conversational intervention Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 80 | Massachusetts General Hospital OTHER |
2026-08-25 |
|
The BASIC-S Feasibility Study for Vascular Risk Reduction NCT07755631 BASIC-S Intervention; Standard / Usual Care Runs in: Canada · 1 site |
NA other |
NOT_YET_RECRUITING | 120 | Andrew Appleton OTHER |
2026-08-25 |
|
Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease NCT07756294 Empagliflozin; Insulin; Insulin Placebo; Empagliflozin Placebo Runs in: United States · 1 site |
PHASE2 other |
NOT_YET_RECRUITING | 30 | Wake Forest University Health Sciences OTHER |
2026-08-25 |
|
Effect of Verbal De-Escalation-Based Simulation on Agitation Management, Perception of Aggression, and Impact of Aggression in Emergency Department Nurses NCT07784868 Standard Verbal De-Escalation Training; Verbal De-Escalation-Based ... Runs in: Turkey (Türkiye) · 1 site |
NA other |
NOT_YET_RECRUITING | 78 | Uskudar University OTHER |
2026-08-25 |
|
A Behavioural Sleep Intervention for People With Mild Cognitive Impairment and Mild Dementia NCT07784946 AI-supported behavioral sleep intervention; control group Runs in: Hong Kong · 1 site |
NA other |
RECRUITING | 60 | The Hong Kong Polytechnic University OTHER |
2026-08-25 |
|
Mindfulness-Based Cognitive Therapy Vs. the Health Enhancement Program for Chronic Pain and Early Cognitive Decline; The Feeling of Being Pilot RCT NCT07785648 Feeling of Being; Health Enhancement Program Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 60 | Massachusetts General Hospital OTHER |
2026-08-25 |
|
The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions NCT07786116 Probiotic Supplementation with L. reuteri Runs in: United Kingdom · 1 site |
NA other |
RECRUITING | 215 | University of Cambridge OTHER |
2026-08-25 |
|
Cognitive Training in Patients With MCI Using fMRI NCT03263247 Visual Memory Training; Alphabet search Runs in: Brazil · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 60 | São Paulo State University OTHER |
2026-08-24 |
|
Preventing Alzheimer's With Cognitive Training NCT03848312 Cognitive Training; Computerized Cognitive Stimulation Runs in: United States · 7 sites |
PHASE3 other |
ACTIVE_NOT_RECRUITING | 7,600 | University of South Florida OTHER |
2026-08-24 |
|
Investigation of Inflammation Using [C-11]-CS1P1 NCT04517552 [11C]-CS1P1 Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 60 | Tammie L. S. Benzinger, MD, PhD OTHER |
2026-08-24 |
|
Intervention on Modifiable Lifestyle Risk Factors for Dementia Prevention NCT04616794 Cognitive Engagement Group; Physical Activity Group; Diet Group; Mu... Runs in: Canada · 1 site |
NA other |
COMPLETED | 41 | LuciLab INDUSTRY |
2026-08-24 |
|
Supporting Family Caregivers of Persons With Dementia NCT05336344 ENCODE Runs in: United States · 1 site |
NA other |
COMPLETED | 452 | University of Pennsylvania OTHER |
2026-08-24 |
|
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease NCT06297590 LY3954068; Placebo; Flortaucipir F18 Runs in: Japan; United Kingdom; United States · 10 sites |
PHASE1 other |
RECRUITING | 48 | Eli Lilly and Company INDUSTRY |
2026-08-24 |
|
Enhancing Attention and Wellbeing Using Digital Therapeutics NCT06397469 MediTrain; Worder Runs in: United States · 1 site |
NA other |
RECRUITING | 4,000 | University of California, San Francisco OTHER |
2026-08-24 |
|
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients NCT06432166 2-hydroxybenzylamine acetate; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
NOT_YET_RECRUITING | 48 | MTI Biotech Inc INDUSTRY |
2026-08-24 |
|
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis NCT07029581 ACP-204; Placebo Runs in: Bulgaria; Czechia; France; Italy; Serbia; United States · 60 sites |
PHASE2 other |
RECRUITING | 180 | ACADIA Pharmaceuticals Inc. INDUSTRY |
2026-08-24 |
|
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau NCT07142278 DUVAX 200 µg; DUVAX 400 µg; Placebo (Adjuvant only) Runs in: United States · 1 site |
PHASE1 other |
NOT_YET_RECRUITING | 24 | Nuravax, Inc. INDUSTRY |
2026-08-24 |
|
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease NCT07178210 Symani Surgical System Runs in: United States · 3 sites |
NA other |
RECRUITING | 15 | MMI (Medical Microinstruments, Inc.) INDUSTRY |
2026-08-24 |
|
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease NCT07571161 Donanemab; Placebo Runs in: China · 30 sites |
PHASE3 anti-amyloid-antibody |
RECRUITING | 140 | Eli Lilly and Company INDUSTRY |
2026-08-24 |
|
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease NCT07779863 Comfy Acupressure for the Elderly; Least acupressure control Runs in: Hong Kong · 1 site |
NA other |
NOT_YET_RECRUITING | 188 | The University of Hong Kong OTHER |
2026-08-24 |
|
A Postmarketing Study of LEQEMBI in United Kingdom (UK) Participants With Alzheimer's Disease (AD) NCT07781345 No Intervention Runs in: United Kingdom · 3 sites |
NA anti-amyloid-antibody |
NOT_YET_RECRUITING | 400 | Eisai Limited INDUSTRY |
2026-08-24 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial